Information on new approvals and medication safety that rheumatologists need to know
Search results for: Primary care
Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?
Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)
ACR/ARHP Annual Meeting 2012: Serum Antibodies Offer Useful Clinical Insights into Systemic Sclerosis
Understanding the role of autoantibodies in systemic sclerosis (SSc) may help predict the course of the disease and guide clinical trials
Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease
Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms
ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists
Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
How to Evaluate Shoulder Pain
The common causes of shoulder pain and diagnostic tests that rheumatologists need to know
What Mick Jagger Can Teach Us About Growing Old Gracefully
Preventive lifestyle behaviors, including regular exercise, can compress morbidity and disability to the very end of our lives, say rheumatologists
ACR/ARHP Annual Meeting 2012: How Rheumatologists Can Negotiate Better Contracts with Payers
Improving contracts with payers can earn rheumatologists more money, with no added costs in staffing or equipment
ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis
Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
- « Previous Page
- 1
- …
- 123
- 124
- 125
- 126
- 127
- …
- 138
- Next Page »